Stay updated on Autologous TILs in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Autologous TILs in Solid Tumors Clinical Trial page.

Latest updates to the Autologous TILs in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedNo significant additions or deletions were observed on the Study Details page between the two screenshots. The core study information (design, eligibility, and outcomes) remains unchanged.SummaryDifference0.2%

- Check30 days agoChange DetectedAdded an operational status notice and updated version to v3.2.0; removed the old v3.1.0 reference.SummaryDifference2%

- Check37 days agoChange Detected- Updated medical terminology to a reordered phrase: from 'Head and neck squamous cell carcinoma' to 'Squamous cell carcinoma of the head and neck'. - Added contact number 1-844-845-4682. - Revision tag updated from v3.0.2 to v3.1.0.SummaryDifference0.3%

- Check52 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2 and the Back to Top link was removed; overall, a minor maintenance change with no impact on core content or pricing.SummaryDifference0.1%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%

- Check66 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as additional drug information, while removing some previous genetic resources and location terms.SummaryDifference7%

Stay in the know with updates to Autologous TILs in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous TILs in Solid Tumors Clinical Trial page.